Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

VEGFR1 / FLT-1 Antikörper

Produkt-Information von VEGFR1 / FLT-1 Antikörper

Immunogen

Recombinant Human VEGFR1 / FLT-1 protein (Catalog#10136-H08H)

Antibody Type Mouse Monoclonal Antibody ( Mouse mAb Service Platform )

Clone ID 

5A4D2

Ig Type

Mouse IgG2a

Formulation 0.2 μm filtered solution in PBS with 5% trehalose
Preparation

This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human VEGFR1 / FLT-1 (rh VEGFR1 / FLT-1; Catalog#10136-H08H; P17948-1; Met 1-Asn 756). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.

VEGFR1 / FLT-1 AntikörperUsage Guide

Specificity

Human VEGFR1 / FLT-1

 

No cross-reactivity in ELISA with

Human VEGFR2

Human VEGFR3

293 cell lysate
Western blot This antibody can be used at 1-2 μg/mL with the appropriate secondary reagents to detect Human VEGFR1 in WB. Using a DAB detection system, the detection limit for Human VEGFR1 is approximately 8 ng/lane under non-reducing conditions and 4 ng/lane under reducing conditions.
Direct ELISA This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Human VEGFR1. The detection limit for Human VEGFR1 is approximately 0.039 ng/well.
Storage This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

Verwandte Produkte & Themen von VEGFR1 / FLT-1 Antikörper

Verwandte Bereiche:

Proteine:

Antikörper:

Hintergrund von VEGFR1 / FLT-1 Antikörper

Vascular endothelial growth factor receptor 1, also known as VEGFR-1, Fms-like tyrosine kinase 1, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, Vascular permeability factor receptor and FLT1, is a single-pass type I membrane protein and secreted protein which belongs to theprotein kinase superfamily, Tyr protein kinase family and CSF-1/PDGF receptor subfamily. VEGFR-1 / FLT1 contains sevenIg-like C2-type (immunoglobulin-like) domains and oneprotein kinase domain. VEGFR-1 / FLT1 is expressed mostly in normal lung, but also in placenta, liver, kidney, heart and brain tissues. It is specifically expressed in most of the vascular endothelial cells, and also expressed in peripheral blood monocytes. VEGFR-1 / FLT1 is not expressed in tumor cell lines. VEGFR-1 / FLT1 is an essential receptor tyrosine kinase that regulates mammalian vascular development and embryogenesis. EGF-induced angiogenesis requires inverse regulation of VEGFR-1 and VEGFR-2 in tumor-associated endothelial cells. VEGFR-1 / FLT1 is a receptor for VEGF, VEGFB and PGF. It has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability.

References

  1. Kendall R.L., et al., 1993, Proc. Natl. Acad. Sci. USA. 90: 10705-9.
  2. Starovasnik M.A., et al., 1999, J. Mol. Biol. 293: 531-44.
  3. Dutta,D. et al., 2008, J Biol Chem. 283 (37): 25404-13.
  4. Mittar,S. et al., 2009, Exp Cell Res.315 (5): 877-89.

Sino Biological Inc. liefert VEGFR1 / FLT-1 Antikörper mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über VEGFR1 / FLT-1 Antikörper lesen Sie bitte: http://www.sinobiological.com/VEGFR1-FLT-1-Antibody-g-8325.html

Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post